Identification and subsequent functional analysis of genetic variants in SIRT1 gene associated with T2D may provide a basis for manipulating SIRT1 gene expression with genetic approaches or pharmaceutical chemicals as potential therapies for T2D patients. The gene discussed is SIRT1; the disease is type 2 diabetes mellitus.